European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

  1. Coghill, D.
  2. Banaschewski, T.
  3. Lecendreux, M.
  4. Soutullo, C.
  5. Johnson, M.
  6. Zuddas, A.
  7. Anderson, C.
  8. Civil, R.
  9. Higgins, N.
  10. Lyne, A.
  11. Squires, L.
Aldizkaria:
European Neuropsychopharmacology

ISSN: 0924-977X,  1873-7862

Argitalpen urtea: 2013

Alea: 23

Zenbakia: 10

Orrialdeak: 1208-1218

Mota: Artikulua

DOI: 10.1016/J.EURONEURO.2012.11.012 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus